Geode Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Sell |
91,841
-7,799
| -8% | -$33.6K | ﹤0.01% | 3633 |
|
|
2025
Q1 | $373K | Buy |
99,640
+6,819
| +7% | +$25.5K | ﹤0.01% | 3649 |
|
|
2024
Q4 | $942K | Buy |
92,821
+2,462
| +3% | +$25K | ﹤0.01% | 3405 |
|
|
2024
Q3 | $1.13M | Buy |
90,359
+2,923
| +3% | +$36.4K | ﹤0.01% | 3313 |
|
|
2024
Q2 | $1.14M | Sell |
87,436
-80,571
| -48% | -$1.05M | ﹤0.01% | 3258 |
|
|
2024
Q1 | $3.81M | Buy |
168,007
+9,178
| +6% | +$208K | ﹤0.01% | 2847 |
|
|
2023
Q4 | $2.06M | Buy |
158,829
+6,353
| +4% | +$82.4K | ﹤0.01% | 3094 |
|
|
2023
Q3 | $3.07M | Buy |
152,476
+10,003
| +7% | +$201K | ﹤0.01% | 2892 |
|
|
2023
Q2 | $3.83M | Buy |
142,473
+24,357
| +21% | +$654K | ﹤0.01% | 2832 |
|
|
2023
Q1 | $6.89M | Buy |
118,116
+26,307
| +29% | +$1.54M | ﹤0.01% | 2481 |
|
|
2022
Q4 | $4.68M | Buy |
91,809
+3,113
| +4% | +$159K | ﹤0.01% | 2701 |
|
|
2022
Q3 | $7.26M | Buy |
88,696
+275
| +0.3% | +$22.5K | ﹤0.01% | 2458 |
|
|
2022
Q2 | $5.98M | Sell |
88,421
-772
| -0.9% | -$52.2K | ﹤0.01% | 2603 |
|
|
2022
Q1 | $9.86M | Sell |
89,193
-6,989
| -7% | -$773K | ﹤0.01% | 2353 |
|
|
2021
Q4 | $9.28M | Buy |
96,182
+2,372
| +3% | +$229K | ﹤0.01% | 2492 |
|
|
2021
Q3 | $8.19M | Buy |
93,810
+14,125
| +18% | +$1.23M | ﹤0.01% | 2607 |
|
|
2021
Q2 | $12.3M | Buy |
79,685
+3,237
| +4% | +$501K | ﹤0.01% | 2310 |
|
|
2021
Q1 | $12.1M | Buy |
76,448
+7,125
| +10% | +$1.12M | ﹤0.01% | 2238 |
|
|
2020
Q4 | $16.1M | Sell |
69,323
-1,033
| -1% | -$240K | ﹤0.01% | 1863 |
|
|
2020
Q3 | $15.4M | Buy |
70,356
+1,517
| +2% | +$332K | ﹤0.01% | 1706 |
|
|
2020
Q2 | $19.6M | Buy |
68,839
+6,617
| +11% | +$1.88M | ﹤0.01% | 1527 |
|
|
2020
Q1 | $17.9M | Buy |
62,222
+7,091
| +13% | +$2.04M | ﹤0.01% | 1373 |
|
|
2019
Q4 | $15.9M | Buy |
55,131
+2,606
| +5% | +$749K | ﹤0.01% | 1711 |
|
|
2019
Q3 | $7.58M | Buy |
52,525
+1,078
| +2% | +$156K | ﹤0.01% | 2111 |
|
|
2019
Q2 | $4.62M | Buy |
51,447
+12,336
| +32% | +$1.11M | ﹤0.01% | 2447 |
|
|
2019
Q1 | $3.43M | Buy |
39,111
+1,916
| +5% | +$168K | ﹤0.01% | 2548 |
|
|
2018
Q4 | $5.23M | Buy |
37,195
+1,757
| +5% | +$247K | ﹤0.01% | 2196 |
|
|
2018
Q3 | $9.05M | Buy |
35,438
+1,065
| +3% | +$272K | ﹤0.01% | 2000 |
|
|
2018
Q2 | $8.76M | Buy |
34,373
+12,951
| +60% | +$3.3M | ﹤0.01% | 1974 |
|
|
2018
Q1 | $4.31M | Buy |
21,422
+2,715
| +15% | +$546K | ﹤0.01% | 2326 |
|
|
2017
Q4 | $2.69M | Buy |
18,707
+1,032
| +6% | +$149K | ﹤0.01% | 2592 |
|
|
2017
Q3 | $2.91M | Buy |
17,675
+314
| +2% | +$51.7K | ﹤0.01% | 2527 |
|
|
2017
Q2 | $2.36M | Buy |
17,361
+6,110
| +54% | +$829K | ﹤0.01% | 2639 |
|
|
2017
Q1 | $2.17M | Buy |
11,251
+818
| +8% | +$158K | ﹤0.01% | 2623 |
|
|
2016
Q4 | $1.47M | Buy |
10,433
+667
| +7% | +$94K | ﹤0.01% | 2800 |
|
|
2016
Q3 | $1.43M | Buy |
9,766
+201
| +2% | +$29.3K | ﹤0.01% | 2746 |
|
|
2016
Q2 | $962K | Buy |
9,565
+317
| +3% | +$31.9K | ﹤0.01% | 2921 |
|
|
2016
Q1 | $1.24K | Buy |
9,248
+5
| +0.1% | +$1 | ﹤0.01% | 2767 |
|
|
2015
Q4 | $1.84M | Buy |
9,243
+158
| +2% | +$31.4K | ﹤0.01% | 2541 |
|
|
2015
Q3 | $1.43M | Buy |
9,085
+283
| +3% | +$44.7K | ﹤0.01% | 2655 |
|
|
2015
Q2 | $3.59M | Buy |
8,802
+594
| +7% | +$242K | ﹤0.01% | 2121 |
|
|
2015
Q1 | $3.77M | Buy |
8,208
+3,054
| +59% | +$1.4M | ﹤0.01% | 2022 |
|
|
2014
Q4 | $2.89M | Sell |
5,154
-23
| -0.4% | -$12.9K | ﹤0.01% | 2184 |
|
|
2014
Q3 | $2.71M | Buy |
5,177
+1,962
| +61% | +$1.03M | ﹤0.01% | 2174 |
|
|
2014
Q2 | $2.24M | Buy |
3,215
+240
| +8% | +$168K | ﹤0.01% | 2303 |
|
|
2014
Q1 | $1.38M | Buy |
2,975
+611
| +26% | +$283K | ﹤0.01% | 2577 |
|
|
2013
Q4 | $812K | Buy |
+2,364
| New | +$812K | ﹤0.01% | 2842 |
|